focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.60
Bid: 64.80
Ask: 65.60
Change: 0.20 (0.31%)
Spread: 0.80 (1.235%)
Open: 65.40
High: 65.60
Low: 64.20
Prev. Close: 65.40
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Idox Compliance

12 Mar 2021 07:00

RNS Number : 0293S
IDOX PLC
12 March 2021
 

12 March 2021

 

Idox plc

('Idox' or the 'Group' or the 'Company')

Disposal of Idox Compliance

 

ldox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, today announces that it has agreed the disposal of its Compliance Operations business, to Sponge Group Limited, a digital learning and technology company, for £9.0m cash on completion. The Compliance Operations business, part of Idox's Content Division is based in Germany and Belgium and employs 48 people.

The transaction will see Sponge acquire the entire share capital of Idox Germany GmbH and Idox Belgium BV together with a number of UK-based customer contracts. Idox Compliance is one of Europe's leading providers of compliance solutions, providing customers with e-learning platforms focused on supporting organisations to comply with compliance law and regulation.

The Compliance Operations reported revenues of £5.3m, an adjusted EBITDA contribution of £1.2m and PBT of £0.3m in Idox's financial year ended 31 October 2020. Gross assets as at 31 October 2020 were £5.4m. The disposal is anticipated to generate a profit on sale of £5.4m in the Group's current financial year.

 

The proceeds of the disposal will be utilised to reduce Idox's net debt (which stood at £16.1m as at 31 October 2020) and to continue to invest its organic and inorganic growth strategy.

Following the disposal, Idox's successful Grants Consultancy business now makes up the entirety of its Content Division.

David Meaden, CEO of Idox said:

"Our strategy, as stated in our recent FY20 results, is to build value as a public-sector focused software organisation. Whilst we are pleased with the progress of our Compliance business in the last two years, within our Four Pillars Framework, this transaction provides us with an opportunity to simplify operations within the Group and focus on our key markets, whilst at the same time providing the Compliance business with a more relevant owner in order to realise its own ambitions.

I look forward to seeing the continued success of the Idox Compliance team and products as it moves into its next phase with Sponge."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The person responsible for making this notification is Ruth Paterson, Company Secretary.

 

-Ends-

Enquiries:

Idox plc +44 (0) 870 333 7101

Chris Stone, Non-Executive ChairmanDavid Meaden, Chief ExecutiveRob Grubb, Chief Financial OfficerPeel Hunt LLP (NOMAD and Broker) +44 (0) 20 7418 8900Edward KnightPaul GillamNick ProwtingMHP Communications  + 44 (0) 203 128 8100Reg Hoare / James Bavister / Amy O'Sullivan idox@mhpc.com 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFFLLFFXLZBBX
Date   Source Headline
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company
30th Aug 20198:18 amRNSHolding(s) in Company
30th Aug 20198:16 amRNSHolding(s) in Company
30th Aug 20197:00 amRNSDirectors' Dealings & Holdings in Company
20th Aug 20199:20 amRNSHolding(s) in Company
9th Aug 20193:16 pmRNSCompletion of Acquisition of Tascomi Ltd
8th Aug 201910:56 amRNSHolding(s) in Company
6th Aug 20198:06 amRNSDirectors' Dealings & Holdings in Company
31st Jul 201910:30 amRNSFurther Details on the Fundraising
31st Jul 20197:00 amRNSProposed Fundraising via accelerated bookbuild
22nd Jul 20197:00 amRNSHalf-year Report
4th Apr 20194:17 pmRNSDirector/PDMR Share Dealing
3rd Apr 20197:00 amRNSBoard Change
29th Mar 20191:08 pmRNSResult of AGM
29th Mar 20197:00 amRNSAGM Trading Update & 2016 Prior Year Adjustment
22nd Mar 20197:00 amRNSDirectorate Change
18th Mar 20195:16 pmRNSOption Awards
12th Mar 20193:17 pmRNSDirector Dealings and Option Awards
7th Mar 20191:29 pmRNSPosting of Annual Report and Notice of AGM
21st Feb 20197:00 amRNSFinal Results for the year ended 31 October 2018
20th Feb 20192:13 pmRNSExercise of Share Options & Total Voting Rights
1st Feb 20198:20 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSExtension of Banking Facilities
22nd Jan 20198:24 amRNSHolding(s) in Company
7th Jan 20192:50 pmRNSBoard Change
27th Nov 20187:00 amRNSYear End Trading Update
22nd Nov 20187:00 amRNSDirectorate Change
19th Nov 20187:00 amRNSDirectorate Change
5th Nov 20187:00 amRNSDisposal of Digital division
31st Oct 20187:00 amRNSDirectorate Change
25th Oct 20183:23 pmRNSHolding(s) in Company
19th Oct 20185:01 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSAppointment of Chief Financial Officer
12th Sep 20183:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.